Product Information
FLUTICASONE PROPIONATE HFA 220 MCG INHALER is a generic product labeled by Prasco Laboratories, priced at $21.8719 per GM under NDC 66993008096. Its NADAC has been published 210 times since Aug 17, 2022.
FDA first approved this application on May 14, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the fluticasone propionate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
220 ug/1
Manufacturer
Prasco LaboratoriesNDC
66993008096
Classification
Generic
Dosage Form
AEROSOL, METERED
Route
RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Active Ingredients
FLUTICASONE PROPIONATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021433FDA Approved
5/14/2004
TE Code
AB
On Market Since
5/23/2022
Pharmacological Classes
Price Statistics
The NADAC for FLUTICASONE PROPIONATE HFA 220 MCG INHALER has been published 210 times since Aug 17, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.8719 per GM |
|---|---|
| All-time high | $22.1537 (Jun 14, 2023) |
| All-time low | $20.0566 (May 22, 2024) |
| 52-week high | $21.9438 |
| 52-week low | $21.5408 |
| Median price | $21.5791 |
| Average price | $21.4556 |
| Largest weekly change | +7.2% (Aug 21, 2024) |
| Weeks tracked | 210 |
| Tracking since | Aug 17, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fluticasone propionate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FLUTICASONE PROPIONATE HFA 220 MCG INHALER?
The current National Average Drug Acquisition Cost (NADAC) for FLUTICASONE PROPIONATE HFA 220 MCG INHALER, manufactured by Prasco Laboratories, is $21.8719 per GM (NDC 66993008096), effective Aug 19, 2026.
How has the price of FLUTICASONE PROPIONATE HFA 220 MCG INHALER changed over time?
Over the history we have for it, the NADAC for FLUTICASONE PROPIONATE HFA 220 MCG INHALER has held within roughly two percent of its current level. It has been tracked across 210 weekly CMS publications since Aug 17, 2022.
What are the highest and lowest recorded NADAC prices for FLUTICASONE PROPIONATE HFA 220 MCG INHALER?
Since Aug 17, 2022, the NADAC for FLUTICASONE PROPIONATE HFA 220 MCG INHALER has ranged from a low of $20.0566 (May 22, 2024) to a high of $22.1537 (Jun 14, 2023), with a median of $21.5791 per GM.
Are there cheaper alternatives to FLUTICASONE PROPIONATE HFA 220 MCG INHALER?
No other NADAC-published product currently shares the active ingredient and strength of FLUTICASONE PROPIONATE HFA 220 MCG INHALER in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FLUTICASONE PROPIONATE HFA 220 MCG INHALER?
FLUTICASONE PROPIONATE HFA 220 MCG INHALER (NDC 66993008096) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.